Robuta

https://www.medicalhalo.com/en/oncology/2245.html HER3-targeted drug: FDA granted breakthrough therapy designation to Patritumab Deruxtecan for the... On December 24, 2021, the FDA granted Breakthrough Therapy Designation to patritumab deruxtecan for the treatment of patients with metastatic or locally... fda grantedfor thetargeteddrugbreakthrough https://www.techtarget.com/pharmalifesciences/news/366607817/FDA-Granted-SirPlux-Duo-Drug-Coated-Balloon-Breakthrough-Designation FDA Granted SirPlux Duo Drug-Coated Balloon Breakthrough Designation | TechTarget In a recent press release, NanoTherapies announced that the FDA granted its SirPlux Duo Drug-Coated Balloon, used to treat coronary artery disease,... fda grantedduodrugcoatedballoon https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2046091&key=Berubicin News for Medical Sales Reps: CNS Announces the FDA has Granted Orphan Drug Designation for Brain... for medicalsales repsthe fdanewscns https://www.biopharmaapac.com/news/33/1163/carsgen-announces-ct041-car-t-cell-product-candidate-granted-rmat-designation-by-the-fda.html CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA by the fdaannouncescarcellproduct https://clpmag.com/uncategorized/clc-covid-19-test-kits-granted-fda-eua/ CLC Covid-19 Test Kits Granted FDA EUA Sep 22, 2020 - Carolina Liquid Chemistries partners with manufacturers to bring needed molecular and antibody test kits and supplies to market during the pandemic. test kitsfda euaclccovidgranted https://www.distilnfo.com/lifesciences/2019/12/31/fda-breakthrough-status-granted-for-heart-failure-algorithm-by-eko/ FDA Breakthrough Status Granted for Heart Failure Algorithm By EKO - DistilINFO LifeSciences Dec 31, 2019 - Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food... Continue Reading heart failurefdabreakthroughstatusgranted https://thedalesreport.com/psychedelics/pharmather-granted-fda-orphan-drug-designation-for-ketamine-to-treat-complex-regional-pain-syndrome/ PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome... Oct 13, 2021 - PharmaTher is pleased to announce that the U.S. FDA has granted ODD for ketamine in the treatment of complex regional pain syndrome (CRPS). regional pain syndromefor ketaminegrantedfdaorphan https://www.nashvillemedicalnews.com/article/3302/enexor-ventilators-granted-fda-emergency-use-authorization Enexor Ventilators Granted FDA Emergency Use Authorization - Nashville Medical News - Healthcare... June 17, 2020 ... Franklin-based Enexor Health systems announced today that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use... medical newsventilatorsgrantedfdaemergency https://www.roche.com/investors/updates/inv-update-2022-07-19 Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely... The Elecsys Amyloid Plasma Panel is intended to be used in conjunction with other clinical information in symptomatic patients who are being evaluated for... rocheamyloidplasmapanelgranted https://new.smallcaps.com.au/article/immutep-granted-fda-orphan-drug-designation-for-efti-in-soft-tissue-sarcoma Immutep Granted FDA Orphan Drug Designation for Efti in Soft Tissue Sarcoma Apr 15, 2026 - Immutep wins FDA Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma, boosting exclusivity and regulatory support as TACTI-004 winds down. soft tissue sarcomaimmutepgrantedfdaorphan https://www.biospace.com/eiger-announces-breakthrough-therapy-designation-granted-by-fda-for-avexitide-for-treatment-of-post-bariatric-hypoglycemia-pbh Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of... Jun 17, 2019 - Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today... eigerannouncesbreakthroughtherapydesignation